MethylprednisoloneLack of efficacy and off-label use in unapproved indication: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2021卷 / 1期

关键词：

D O I：

10.1007/s40278-024-65098-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：303 / 303

相关论文

共 50 条

[1] Antipsoriatics/dupilumabLack of efficacy and off-label use in unapproved indication: case report
[J]. Reactions Weekly, 2023, 1961 (1) : 66 - 66
[2] MethylprednisoloneLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1934 (1) : 275 - 275
[3] Dapsone/dupilumabMethaemoglobinaemia and off-label use in unapproved indication: case report
[J]. Reactions Weekly, 2023, 1986 (1) : 161 - 161
[4] MethylprednisoloneLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1902 (1) : 280 - 280
[5] Loperamide/methylprednisoloneLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1965 (1) : 286 - 286
[6] Multiple drugsDrug intolerance, lack of efficacy and off-label use (in unapproved indication): case report
[J]. Reactions Weekly, 2023, 1979 (1) : 299 - 299
[7] Abatacept/cyclophosphamideLack of efficacy and off-label use in unapproved indication
[J]. Reactions Weekly, 2024, 2006 (1) : 13 - 13
[8] Ciclosporin/cyclophosphamide/methylprednisoloneLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1897 (1) : 110 - 110
[9] Azithromycin/hydroxychloroquine/steroidsLack of efficacy and off-label use in an unapproved indication
[J]. Reactions Weekly, 2024, 2014 (1) : 104 - 104
[10] Multiple drugsLack of efficacy and off-label use (in unapproved indication): 4 case reports
[J]. Reactions Weekly, 2023, 1966 (1) : 245 - 245

← 1 2 3 4 5 →